
LIVE Fireside Chat: Exploring New Treatment Options for High-Risk Prostate Cancer
The EvoPAR Pro2 clinical trial is designed for men with high-risk prostate cancer linked to BRCA1 or BRCA2 gene changes who have completed radiation treatment and are currently receiving hormone therapy. Researchers are studying whether adding the investigational medication saruparib to standard treatment may help delay, slow down, or prevent the cancer from spreading to […]
